Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.

Bornholdt ZA, Herbert AS, Mire CE, He S, Cross RW, Wec AZ, Abelson DM, Geisbert JB, James RM, Rahim MN, Zhu W, Borisevich V, Banadyga L, Gunn BM, Agans KN, Wirchnianski AS, Goodwin E, Tierney K, Shestowsky WS, Bohorov O, Bohorova N, Velasco J, Ailor E, Kim D, Pauly MH, Whaley KJ, Alter G, Walker LM, Chandran K, Zeitlin L, Qiu X, Geisbert TW, Dye JM.

Cell Host Microbe. 2019 Jan 9;25(1):49-58.e5. doi: 10.1016/j.chom.2018.12.005.

PMID:
30629918
2.

Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection.

Wec AZ, Bornholdt ZA, He S, Herbert AS, Goodwin E, Wirchnianski AS, Gunn BM, Zhang Z, Zhu W, Liu G, Abelson DM, Moyer CL, Jangra RK, James RM, Bakken RR, Bohorova N, Bohorov O, Kim DH, Pauly MH, Velasco J, Bortz RH 3rd, Whaley KJ, Goldstein T, Anthony SJ, Alter G, Walker LM, Dye JM, Zeitlin L, Qiu X, Chandran K.

Cell Host Microbe. 2019 Jan 9;25(1):39-48.e5. doi: 10.1016/j.chom.2018.12.004.

PMID:
30629917
3.

Controversies and emerging topics in lung transplantation.

Abelson D, Glanville AR.

Breathe (Sheff). 2018 Dec;14(4):278-287. doi: 10.1183/20734735.027018.

4.

Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.

Wec AZ, Herbert AS, Murin CD, Nyakatura EK, Abelson DM, Fels JM, He S, James RM, de La Vega MA, Zhu W, Bakken RR, Goodwin E, Turner HL, Jangra RK, Zeitlin L, Qiu X, Lai JR, Walker LM, Ward AB, Dye JM, Chandran K, Bornholdt ZA.

Cell. 2017 May 18;169(5):878-890.e15. doi: 10.1016/j.cell.2017.04.037.

5.

The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis.

Kirchdoerfer RN, Moyer CL, Abelson DM, Saphire EO.

PLoS Pathog. 2016 Oct 18;12(10):e1005937. doi: 10.1371/journal.ppat.1005937. eCollection 2016 Oct.

6.

Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.

Cross RW, Boisen ML, Millett MM, Nelson DS, Oottamasathien D, Hartnett JN, Jones AB, Goba A, Momoh M, Fullah M, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Brown BL, Pham H, Rowland MM, Agans KN, Geisbert JB, Heinrich ML, Kulakosky PC, Shaffer JG, Schieffelin JS, Kargbo B, Gbetuwa M, Gevao SM, Wilson RB, Saphire EO, Pitts KR, Khan SH, Grant DS, Geisbert TW, Branco LM, Garry RF.

J Infect Dis. 2016 Oct 15;214(suppl 3):S210-S217. Epub 2016 Aug 31.

7.

Crystal Structure of Marburg Virus VP40 Reveals a Broad, Basic Patch for Matrix Assembly and a Requirement of the N-Terminal Domain for Immunosuppression.

Oda S, Noda T, Wijesinghe KJ, Halfmann P, Bornholdt ZA, Abelson DM, Armbrust T, Stahelin RV, Kawaoka Y, Saphire EO.

J Virol. 2015 Dec 9;90(4):1839-48. doi: 10.1128/JVI.01597-15. Print 2016 Feb 15.

8.

Laryngospasm notch pressure ('Larson's maneuver') may have a role in laryngospasm management in children: highlighting a so far unproven technique.

Abelson D.

Paediatr Anaesth. 2015 Nov;25(11):1175-6. doi: 10.1111/pan.12731. No abstract available.

PMID:
26426878
9.

Development of Prototype Filovirus Recombinant Antigen Immunoassays.

Boisen ML, Oottamasathien D, Jones AB, Millett MM, Nelson DS, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Hartnett JN, Rowland MM, Heinrich ML, Akdag M, Goba A, Momoh M, Fullah M, Baimba F, Gbakie M, Safa S, Fonnie R, Kanneh L, Cross RW, Geisbert JB, Geisbert TW, Kulakosky PC, Grant DS, Shaffer JG, Schieffelin JS, Wilson RB, Saphire EO, Branco LM, Garry RF, Khan SH, Pitts KR; Viral Hemorrhagic Fever Consortium.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S359-67. doi: 10.1093/infdis/jiv353. Epub 2015 Jul 30.

10.

Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex.

Kirchdoerfer RN, Abelson DM, Li S, Wood MR, Saphire EO.

Cell Rep. 2015 Jul 7;12(1):140-149. doi: 10.1016/j.celrep.2015.06.003. Epub 2015 Jun 25.

11.

Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak.

Boisen ML, Schieffelin JS, Goba A, Oottamasathien D, Jones AB, Shaffer JG, Hastie KM, Hartnett JN, Momoh M, Fullah M, Gabiki M, Safa S, Zandonatti M, Fusco M, Bornholdt Z, Abelson D, Gire SK, Andersen KG, Tariyal R, Stremlau M, Cross RW, Geisbert JB, Pitts KR, Geisbert TW, Kulakoski P, Wilson RB, Henderson L, Sabeti PC, Grant DS, Garry RF, Saphire EO, Branco LM, Khan SH; Viral Hemorrhagic Fever Consortium.

Viral Immunol. 2015 Feb;28(1):19-31. doi: 10.1089/vim.2014.0108.

12.

Crystal structure of Marburg virus VP24.

Zhang AP, Bornholdt ZA, Abelson DM, Saphire EO.

J Virol. 2014 May;88(10):5859-63. doi: 10.1128/JVI.03565-13. Epub 2014 Feb 26.

13.

Assessment of ventriculo-arterial interaction in pulmonary arterial hypertension using wave intensity analysis.

Lau EM, Abelson D, Dwyer N, Yu Y, Ng MK, Celermajer DS.

Eur Respir J. 2014 Jun;43(6):1804-7. doi: 10.1183/09031936.00148313. Epub 2014 Jan 16. No abstract available.

14.

Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle.

Bornholdt ZA, Noda T, Abelson DM, Halfmann P, Wood MR, Kawaoka Y, Saphire EO.

Cell. 2013 Aug 15;154(4):763-74. doi: 10.1016/j.cell.2013.07.015.

15.

The ebolavirus VP24 interferon antagonist: know your enemy.

Zhang AP, Abelson DM, Bornholdt ZA, Liu T, Woods VL Jr, Saphire EO.

Virulence. 2012 Aug 15;3(5):440-5. doi: 10.4161/viru.21302. Epub 2012 Aug 15.

16.

The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.

Zhang AP, Bornholdt ZA, Liu T, Abelson DM, Lee DE, Li S, Woods VL Jr, Saphire EO.

PLoS Pathog. 2012 Feb;8(2):e1002550. doi: 10.1371/journal.ppat.1002550. Epub 2012 Feb 23. Erratum in: PLoS Pathog. 2013 Dec;9(12). doi:10.1371/annotation/360ddc68-0313-4eae-af24-043cc040c52d.

17.

Influence of alcohol on perioperative cognitive decline.

Abelson DM.

Mayo Clin Proc. 2012 Feb;87(2):210; author reply 210. doi: 10.1016/j.mayocp.2011.12.006. No abstract available.

18.

Evaluation of a metal artifact reduction technique in tonsillar cancer delineation.

Abelson JA, Murphy JD, Wiegner EA, Abelson D, Sandman DN, Boas FE, Hristov D, Fleischmann D, Daly ME, Chang DT, Loo BW Jr, Hara W, Le QT.

Pract Radiat Oncol. 2012 Jan-Mar;2(1):27-34. doi: 10.1016/j.prro.2011.06.004. Epub 2011 Jul 20.

PMID:
24674033
19.

Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion.

Bale S, Liu T, Li S, Wang Y, Abelson D, Fusco M, Woods VL Jr, Saphire EO.

PLoS Negl Trop Dis. 2011 Nov;5(11):e1395. doi: 10.1371/journal.pntd.0001395. Epub 2011 Nov 15.

20.

A shared structural solution for neutralizing ebolaviruses.

Dias JM, Kuehne AI, Abelson DM, Bale S, Wong AC, Halfmann P, Muhammad MA, Fusco ML, Zak SE, Kang E, Kawaoka Y, Chandran K, Dye JM, Saphire EO.

Nat Struct Mol Biol. 2011 Nov 20;18(12):1424-7. doi: 10.1038/nsmb.2150.

21.

Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein.

Lee JE, Fusco ML, Abelson DM, Hessell AJ, Burton DR, Saphire EO.

Acta Crystallogr D Biol Crystallogr. 2009 Nov;65(Pt 11):1162-80. doi: 10.1107/S0907444909032314. Epub 2009 Oct 22.

22.

Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain.

Lee JE, Kuehne A, Abelson DM, Fusco ML, Hart MK, Saphire EO.

J Mol Biol. 2008 Jan 4;375(1):202-16. Epub 2007 Oct 16.

23.

Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.

Magarvey NA, Beck ZQ, Golakoti T, Ding Y, Huber U, Hemscheidt TK, Abelson D, Moore RE, Sherman DH.

ACS Chem Biol. 2006 Dec 15;1(12):766-79.

PMID:
17240975
24.

A work-sampling tool to measure the effect of electronic medical record implementation on health care workers.

Fontaine BR, Speedie S, Abelson D, Wold C.

J Ambul Care Manage. 2000 Jan;23(1):71-85.

PMID:
11184897
25.

Stereophonic stethoscope with teaching attachment.

Abelson D.

Am J Cardiol. 2000 Mar 1;85(5):669-71, A11.

PMID:
11078290
26.
27.

Comparative study of plaque pH on enamel and cemental surfaces.

Abelson DC, Mandel ID.

J Clin Dent. 1990;2(1):1-2.

PMID:
2133388
28.

The effect of hydrogenated starch hydrolysates on plaque pH in vivo.

Abelson DC.

Clin Prev Dent. 1989 Mar-Apr;11(2):20-3.

PMID:
2598577
29.

Effect of sorbitol sweetened breath mints on salivary flow and plaque pH in xerostomic subjects.

Abelson DC, Barton J, Mandel ID.

J Clin Dent. 1989 Spring;1(4):102-5.

PMID:
2639688
30.

Sorbitol gum in xerostomics: the effects on dental plaque pH and salivary flow rates.

Markovic N, Abelson DC, Mandel ID.

Gerodontology. 1988 Summer;7(2):71-5. No abstract available.

PMID:
3273285
31.

The clinical efficacy of wooden interdental cleaners in gingivitis reduction.

Barton J, Abelson D.

Clin Prev Dent. 1987 Nov-Dec;9(6):17-20. No abstract available.

PMID:
3509816
32.

Modification of dental plaque by arginine-urea to resist pH fall in vivo.

Abelson DC, Vratsanos SM, Mandel ID.

Clin Prev Dent. 1986 Jan-Feb;8(1):7-10. No abstract available.

PMID:
3485496
33.

Denture plaque and denture cleansers: review of the literature.

Abelson DC.

Gerodontics. 1985 Oct;1(5):202-6. Review. No abstract available.

PMID:
3005102
34.

The effect of sucrose concentration on plaque pH in vivo.

Abelson DC, Pergola G.

Clin Prev Dent. 1984 Mar-Apr;6(2):23-6. No abstract available.

PMID:
6331944
35.

The effect of saliva on plaque pH in vivo.

Abelson DC, Mandel ID.

J Dent Res. 1981 Sep;60(9):1634-8.

PMID:
6943155
36.

Evaluation of interproximal cleaning by two types of dental floss.

Abelson DC, Barton JE, Maietti GM, Cowherd MG.

Clin Prev Dent. 1981 Jul-Aug;3(4):19-21. No abstract available.

PMID:
6976870
37.

Denture plaque and denture cleansers.

Abelson DC.

J Prosthet Dent. 1981 Apr;45(4):376-9.

PMID:
6939844
38.

Bedside measurement of systolic and diastolic time intervals using the stethometer.

Abelson D, Kamens EA.

Cardiovasc Res. 1977 May;11(3):270-4.

PMID:
872166
39.

Multiple use of fluoride for adult patients.

Abelson DC, Levin MP.

N Y J Dent. 1977 May;47(5):146-8. No abstract available.

PMID:
265465
40.

Salivary studies in alcoholic cirrhosis.

Abelson DC, Mandel ID, Karmiol M.

Oral Surg Oral Med Oral Pathol. 1976 Feb;41(2):188-92.

PMID:
1062747
41.

Salivary alterations in diabetes mellitus.

Marder MZ, Abelson DC, Mandel ID.

J Periodontol. 1975 Sep;46(9):567-9.

PMID:
1057651
42.
43.

Letter: Toward greater patient safety.

Abelson D.

JAMA. 1974 Oct 14;230(2):212. No abstract available.

PMID:
4479227
44.

The effect of surgical procedure on salivary electrolytes.

Abelson DC, Wotman S, Mandel ID, Marcus L, Waldo AL.

J Oral Med. 1974 Apr-Jun;29(2):41-4. No abstract available.

PMID:
4524265
45.

Letter: Towards more accurate blood pressure readings.

Abelson D.

JAMA. 1974 Mar 25;227(12):1381. No abstract available.

PMID:
4406011
46.

The effect of various disclosants on plaque accumulation in human subjects.

Goldman RS, Abelson DC, Mandel ID, Chilton NW.

J Periodontal Res. 1974;9(6):381-5. No abstract available.

PMID:
4142045
47.

Reciprocal movement of the right and left heart, demonstrated by directional Doppler ultrasound.

Abelson D, Müller HR.

Am Heart J. 1973 Nov;86(5):651-2. No abstract available.

PMID:
4743333
48.

Society for the promotion of involuntary tranquilization (SPIT).

Abelson D.

JAMA. 1972 Aug 7;221(6):603. No abstract available.

PMID:
5068091
49.

Analysis of the Doppler signals from the fetal heart.

Abelson D, Balin H.

Am J Obstet Gynecol. 1972 Mar 15;112(6):796-801. No abstract available.

PMID:
5019416
50.

Left ventricular pseudoaneurysm. A rare complication of open-heart surgery with unusual Doppler manifestations.

Fallah-nejad M, Abelson DM, Blakemore WS.

Chest. 1972 Jan;61(1):90-2. No abstract available.

PMID:
5049512

Supplemental Content

Loading ...
Support Center